KPC(SH:600422)2017-04-27 16:00Financial Performance - Operating revenue for the period was CNY 1,215,145,409.67, reflecting a year-on-year growth of 6.07%[5] - Net profit attributable to shareholders was CNY 94,441,874.34, representing a 10.61% increase from the previous year[5] - Basic earnings per share rose to CNY 0.1197, marking a 10.53% increase year-on-year[5] - Net profit for Q1 2017 reached CNY 94,971,747.14, representing a 10.5% increase compared to CNY 85,938,778.49 in Q1 2016[26] - Earnings per share for Q1 2017 was CNY 0.1197, up from CNY 0.1083 in the previous year, indicating a growth of 10.8%[26] - The net profit for the current period was ¥64,043,999.55, representing a growth of 8.5% from ¥59,241,254.82 in the previous period[28] - The total profit amounted to ¥75,345,881.18, up by 8.5% from ¥69,695,593.90 in the previous period[28] Cash Flow - The net cash flow from operating activities was negative CNY 72,556,811.44, a decline of 220.98% compared to the same period last year[5] - Cash flow from operating activities showed a net outflow of ¥72,556,811.44, compared to a net inflow of ¥59,974,255.06 in the previous period[30] - The net cash flow from operating activities was -$35.71 million, a decrease from $70.56 million in the previous year[32] - Cash outflow from operating activities amounted to $497.04 million, compared to $335.73 million in the previous year[32] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 5,441,248,619.57, an increase of 0.72% compared to the end of the previous year[5] - Total liabilities decreased to ¥1,733,306,506.20 from ¥1,790,254,846.35[18] - Total equity increased to ¥3,707,942,113.37 from ¥3,612,008,496.21[18] - Total assets as of March 31, 2017, amounted to ¥5,441,248,619.57, a slight increase from ¥5,402,263,342.56 at the beginning of the year[17] - Total liabilities for Q1 2017 were CNY 851,589,993.53, an increase from CNY 810,296,234.36 in the same period last year, reflecting a growth of 5.1%[22] - The company's total equity as of Q1 2017 was CNY 3,296,693,588.61, up from CNY 3,232,649,589.06, indicating a year-over-year increase of 1.98%[22] Government Subsidies and Other Income - The company received government subsidies amounting to CNY 6,610,019.42, which are closely related to its normal business operations[6] - Operating income from non-operating activities increased by 114% to ¥7,408,281.51 due to increased government subsidies[12] - Non-recurring gains and losses totaled CNY 10,864,708.47 for the period[7] Shareholder Information - The total number of shareholders at the end of the reporting period was 47,436[9] - The largest shareholder, Huafang Pharmaceutical Technology Co., Ltd., held 29.79% of the shares, with 234,928,716 shares pledged[9] Investment Activities - Net cash flow from investing activities increased by 235% to ¥323,146,666.62 primarily due to the redemption of financial products[12] - The company reported cash inflows from investment activities of ¥1,509,672,047.56, an increase from ¥1,069,505,103.80 in the previous period[30] - The cash received from investment recoveries was $1.16 billion, an increase from $800.80 million in the previous year[32] Operating Costs and Expenses - Total operating costs for Q1 2017 were CNY 1,112,736,837.21, up from CNY 1,050,998,708.06, reflecting a year-over-year increase of 5.84%[25] - The total operating expenses increased to ¥95,182,368.02 from ¥84,597,744.35 in the previous period, reflecting a rise of 12.5%[28]